Grace Therapeutics, Inc. (GRCE) Net income 2019–2026
Grace Therapeutics, Inc. (GRCE) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$7.8MFY2026 · since FY2019: -$39.4M → -$7.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2026 | -$7.8M | +18.6% |
| FY2025 | -$9.6M | +25.6% |
| FY2024 | -$12.9M | +69.7% |
| FY2023 | -$42.4M | -332.1% |
| FY2022 | -$9.8M | +50.1% |
| FY2021 | -$19.7M | +22.9% |
| FY2020 | -$25.5M | +35.2% |
| FY2019 | -$39.4M | — |
Source: SEC XBRL filings · For reference only · Not investment advice